Literature DB >> 22299058

Cells diversify transmembrane signaling through the controlled chaos of protein disorder.

Alexander B Sigalov1.   

Abstract

Cell surface receptors function to transduce signals across the cell membrane leading to a variety of biologic responses. Structurally, these integral proteins can be classified into two main families, depending on whether extracellular ligand-binding and intracellular signaling domains are located on the same protein chain (single-chain receptors, SRs) or on separate subunits (multichain receptors, MRs). Since most MRs are immune receptors, they are all commonly referred to as multi-chain immune recognition receptors (MIRRs). Recent studies reveal that, in contrast to well-structured signaling domains of SRs, those of MIRRs represent intrinsically disordered regions, the regions that lack a well-defined three-dimensional structure under physiological conditions. Why did nature separate recognition and signaling functions of MIRRs? Why for MIRRs did nature select to provide highly specific signaling through the chaos of protein disorder? What mechanisms could control this chaos in the process of transmembrane signal transduction to provide the specificity and diversity of the immune response? Here, I summarize recent findings that may not only shed light on these and other questions but also add significantly to our understanding of receptor signaling, a fundamental process that plays a critical role in health and disease.

Entities:  

Year:  2011        PMID: 22299058      PMCID: PMC3268992          DOI: 10.4161/self.2.2.15756

Source DB:  PubMed          Journal:  Self Nonself        ISSN: 1938-2030


  54 in total

Review 1.  Protein-protein interactions as a target for drugs in proteomics.

Authors:  Alexander I Archakov; Vadim M Govorun; Alexander V Dubanov; Yuri D Ivanov; Alexander V Veselovsky; Paul Lewi; Paul Janssen
Journal:  Proteomics       Date:  2003-04       Impact factor: 3.984

Review 2.  The avian B-cell receptor complex: distinct roles of Igalpha and Igbeta in B-cell development.

Authors:  Kelly A Pike; Ehtesham Baig; Michael J H Ratcliffe
Journal:  Immunol Rev       Date:  2004-02       Impact factor: 12.988

3.  HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.

Authors:  Francisco J Quintana; Doron Gerber; Sally C Kent; Irun R Cohen; Yechiel Shai
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

4.  Independent trafficking of Ig-alpha/Ig-beta and mu-heavy chain is facilitated by dissociation of the B cell antigen receptor complex.

Authors:  Jin-Hyang Kim; Lorraine Cramer; Heather Mueller; Bridget Wilson; Barbara J Vilen
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

5.  Lipid-binding activity of intrinsically unstructured cytoplasmic domains of multichain immune recognition receptor signaling subunits.

Authors:  Alexander B Sigalov; Dikran A Aivazian; Vladimir N Uversky; Lawrence J Stern
Journal:  Biochemistry       Date:  2006-12-19       Impact factor: 3.162

6.  The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgamma-mediated cell activation signals.

Authors:  S Lin; C Cicala; A M Scharenberg; J P Kinet
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

Review 7.  Protein intrinsic disorder and oligomericity in cell signaling.

Authors:  Alexander B Sigalov
Journal:  Mol Biosyst       Date:  2009-11-03

8.  Antigen-stimulated dissociation of BCR mIg from Ig-alpha/Ig-beta: implications for receptor desensitization.

Authors:  B J Vilen; T Nakamura; J C Cambier
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

9.  Qualitatively differential regulation of T cell activation and apoptosis by T cell receptor zeta chain ITAMs and their tyrosine residues.

Authors:  Wook-Jin Chae; Heung-Kyu Lee; Jin-Hwan Han; Sang-Won Vincent Kim; Alfred L M Bothwell; Tomohiro Morio; Sang-Kyou Lee
Journal:  Int Immunol       Date:  2004-08-09       Impact factor: 4.823

10.  Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor.

Authors:  L A Chau; J A Bluestone; J Madrenas
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

View more
  2 in total

Review 1.  Evolution of immunity: no development without risk.

Authors:  Alexander B Sigalov
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 2.  Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old.

Authors:  Alexander B Sigalov
Journal:  Adv Protein Chem Struct Biol       Date:  2017-07-24       Impact factor: 3.507

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.